New Key Statistics Module, Z-Score and F-Score
NAS:VNDA Key Ratios
Market Cap $ M | 294.02 |
Enterprise Value $ M | -92.90 |
P/E(ttm) | 98.27 |
PE Ratio without NRI | 98.27 |
Forward PE Ratio | -- |
Price/Book | 0.54 |
Price/Sales | 1.53 |
Price/Free Cash Flow | 23.55 |
Price/Owner Earnings | 106.45 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 192.00 |
EPS (TTM) $ | 0.05 |
Beneish M-Score | -2.24 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -219.50 |
EV-to-EBIT | 6.66 |
EV-to-EBITDA | 8.49 |
PEG | -- |
Shares Outstanding M | 57.54 |
Net Margin (%) | 1.30 |
Operating Margin % | -7.24 |
Pre-tax Margin (%) | 3.29 |
Quick Ratio | 4.92 |
Current Ratio | 4.94 |
ROA % (ttm) | 0.39 |
ROE % (ttm) | 0.47 |
ROIC % (ttm) | -2.90 |
Dividend Yield % | -- |
Altman Z-Score | 2.29 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | N |
VNDA Number of Guru Trades
VNDA Volume of Guru Trades
Gurus Latest Trades with NAS:VNDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VNDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vanda Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VNDA
Total 0- 1